Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Pharmaceuticals: Global Industry Guide

Published by: Datamonitor

Published: Apr. 1, 2009 - 250 Pages


Table of Contents


CHAPTER 1 INTRODUCTION
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions
CHAPTER 2 GLOBAL OTC PHARMACEUTICALS
2.1 Market Overview
2.2 Market Value
2.3 Market Segmentation I
2.4 Market Segmentation II
2.5 Market Share
2.6 Five Forces Analysis
2.7 Distribution
2.8 Market Forecasts
CHAPTER 3 OTC PHARMACEUTICALS IN ASIA-PACIFIC
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Distribution
3.8 Market Forecasts
CHAPTER 4 OTC PHARMACEUTICALS IN EUROPE
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
4.7 Distribution
4.8 Market Forecasts
4.9 Macroeconomic Indicators
CHAPTER 5 OTC PHARMACEUTICALS IN BELGIUM
5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share
5.6 Five Forces Analysis
5.7 Distribution
5.8 Market Forecasts
5.9 Macroeconomic Indicators
CHAPTER 6 OTC PHARMACEUTICALS IN CANADA
6.1 Market Overview
6.2 Market Value
6.3 Market Segmentation I
6.4 Market Segmentation II
6.5 Market Share
6.6 Five Forces Analysis
6.7 Distribution
6.8 Market Forecasts
6.9 Macroeconomic Indicators
CHAPTER 7 OTC PHARMACEUTICALS IN CHINA
7.1 Market Overview
7.2 Market Value
7.3 Market Segmentation I
7.4 Market Segmentation II
7.5 Market Share
7.6 Five Forces Analysis
7.7 Distribution
7.8 Market Forecasts
7.9 Macroeconomic Indicators
CHAPTER 8 OTC PHARMACEUTICALS IN FRANCE
8.1 Market Overview
8.2 Market Value
8.3 Market Segmentation I
8.4 Market Segmentation II
8.5 Market Share
8.6 Five Forces Analysis
8.7 Distribution
8.8 Market Forecasts
8.9 Macroeconomic Indicators
CHAPTER 9 OTC PHARMACEUTICALS IN GERMANY
9.1 Market Overview
9.2 Market Value
9.3 Market Segmentation I
9.4 Market Segmentation II
9.5 Market Share
9.6 Five Forces Analysis
9.7 Distribution
9.8 Market Forecasts
9.9 Macroeconomic Indicators
CHAPTER 10 OTC PHARMACEUTICALS IN ITALY
10.1 Market Overview
10.2 Market Value
10.3 Market Segmentation I
10.4 Market Segmentation II
10.5 Market Share
10.6 Five Forces Analysis
10.7 Distribution
10.8 Market Forecasts
10.9 Macroeconomic Indicators
CHAPTER 11 OTC PHARMACEUTICALS IN JAPAN
11.1 Market Overview
11.2 Market Value
11.3 Market Segmentation I
11.4 Market Segmentation II
11.5 Market Share
11.6 Five Forces Analysis
11.7 Distribution
11.8 Market Forecasts
11.9 Macroeconomic Indicators
CHAPTER 12 OTC PHARMACEUTICALS IN THE NETHERLANDS
12.1 Market Overview
12.2 Market Value
12.3 Market Segmentation I
12.4 Market Segmentation II
12.5 Market Share
12.6 Five Forces Analysis
12.7 Distribution
12.8 Market Forecasts
12.9 Macroeconomic Indicators
CHAPTER 13 OTC PHARMACEUTICALS IN SPAIN
13.1 Market Overview
13.2 Market Value
13.3 Market Segmentation I
13.4 Market Segmentation II
13.5 Market Share
13.6 Five Forces Analysis
13.7 Distribution
13.8 Market Forecasts
13.9 Macroeconomic Indicators
CHAPTER 14 OTC PHARMACEUTICALS IN THE UNITED KINGDOM
14.1 Market Overview
14.2 Market Value
14.3 Market Segmentation I
14.4 Market Segmentation II
14.5 Market Share
14.6 Five Forces Analysis
14.7 Distribution
14.8 Market Forecasts
14.9 Macroeconomic Indicators
CHAPTER 15 OTC PHARMACEUTICALS IN THE UNITED STATES
15.1 Market Overview
15.2 Market Value
15.3 Market Segmentation I
15.4 Market Segmentation II
15.5 Market Share
15.6 Five Forces Analysis
15.7 Distribution
15.8 Market Forecasts
15.9 Macroeconomic Indicators
CHAPTER 16 COMPANY PROFILES
16.1 Leading Companies
CHAPTER 17 APPENDIX
17.1 Data Research Methodology
LIST OF TABLES
Table 1: Global OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 5: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 6: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 7: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 8: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 9: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 10: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 11: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 12: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 13: Europe OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 14: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 15: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 16: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 17: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 18: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 19: Europe Exchange Rate, 2004- 2008(e)
Table 20: Belgium OTC Pharmaceuticals Market Value: $ million, 2004- 2008(e)
Table 21: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 22: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 23: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 24: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 25: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
Table 26: Belgium Size of Population (million) , 2004- 2008(e)
Table 27: Belgium GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 28: Belgium Inflation, 2004- 2008(e)
Table 29: Belgium Exchange Rate, 2004- 2008(e)
Table 30: Canada OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 31: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 32: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 33: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 34: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 35: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 36: Canada Size of Population (million) , 2004- 2008(e)
Table 37: Canada GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 38: Canada Inflation, 2004- 2008(e)
Table 39: Canada Exchange Rate, 2004- 2008(e)
Table 40: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 41: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 42: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 43: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 44: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 45: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 46: China Size of Population (million) , 2004-2008(e)
Table 47: China GDP (Constant 2000 Prices, $ billion), 2004-2008(e)
Table 48: China Inflation, 2004-2008(e)
Table 49: China Exchange Rate, 2004-2008(e)
Table 50: France OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Table 51: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 52: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 53: France OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 54: France OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 55: France OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 56: France Size of Population (million) , 2004- 2008(e)
Table 57: France GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 58: France Inflation, 2004- 2008(e)
Table 59: France Exchange Rate, 2004- 2008(e)
Table 60: Germany OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 61: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 62: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 63: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 64: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 65: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 66: Germany Size of Population (million) , 2004- 2008(e)
Table 67: Germany GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 68: Germany Inflation, 2004- 2008(e)
Table 69: Germany Exchange Rate, 2004- 2008(e)
Table 70: Italy OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Table 71: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 72: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 73: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 74: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 75: Italy OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 76: Italy Size of Population (million) , 2004- 2008(e)
Table 77: Italy GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 78: Italy Inflation, 2004- 2008(e)
Table 79: Italy Exchange Rate, 2004- 2008(e)
Table 80: Japan OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Table 81: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 82: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 83: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 84: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 85: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 86: Japan Size of Population (million) , 2004-2008(e)
Table 87: Japan GDP (Constant 2000 Prices, $ billion), 2004-2008(e)
Table 88: Japan Inflation, 2004-2008(e)
Table 89: Japan Exchange Rate, 2004-2008(e)
Table 90: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004- 2008(e)
Table 91: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 92: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 93: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 94: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 95: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
Table 96: Netherlands Size of Population (million) , 2004-2008(e)
Table 97: Netherlands GDP (Constant 2000 Prices, $ billion), 2004-2008(e)
Table 98: Netherlands Inflation, 2004-2008(e)
Table 99: Netherlands Exchange Rate, 2004-2008(e)
Table 100: Spain OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Table 101: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 102: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 103: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 104: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 105: Spain OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 106: Spain Size of Population (million) , 2004- 2008(e)
Table 107: Spain GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 108: Spain Inflation, 2004- 2008(e)
Table 109: Spain Exchange Rate, 2004- 2008(e)
Table 110: United Kingdom OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Table 111: United Kingdom OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 112: United Kingdom OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 113: United Kingdom OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 114: United Kingdom OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 115: United Kingdom OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 116: United Kingdom Size of Population (million) , 2004-2008(e)
Table 117: United Kingdom GDP (Constant 2000 Prices, $ billion), 2004-2008(e)
Table 118: United Kingdom Inflation, 2004-2008(e)
Table 119: United Kingdom Exchange Rate, 2004-2008(e)
Table 120: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Table 121: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 122: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 123: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 124: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Table 125: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 126: United States Size of Population (million) , 2004- 2008(e)
Table 127: United States GDP (Constant 2000 Prices, $ billion), 2004- 2008(e)
Table 128: United States Inflation, 2004- 2008(e)
Table 129: Key Facts: Pfizer Inc
Table 130: Key Financials: Pfizer Inc
Table 131: Key Facts: GlaxoSmithKline Plc
Table 132: Key Financials: GlaxoSmithKline Plc
Table 133: Key Facts: Novartis AG
Table 134: Key Financials: Novartis AG
Table 135: Key Facts: Bayer AG
Table 136: Key Financials: Bayer AG
LIST OF FIGURES
Figure 1: Global OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 5: Forces Driving Competition in the Global OTC Pharmaceuticals Market
Figure 6: Drivers of Buyer Power in the Global OTC Pharmaceuticals Market
Figure 7: Drivers of Supplier Power in the Global OTC Pharmaceuticals Market
Figure 8: Factors Influencing the Likelihood of New Entrants in the Global OTC Pharmaceuticals Market
Figure 9: Factors Influencing the Threat of Substitutes in the Global OTC Pharmaceuticals Market
Figure 10: Drivers of Degree of Rivalry in the Global OTC Pharmaceuticals Market
Figure 11: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 12: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 13: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 14: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 15: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 16: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 17: Forces Driving Competition in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 18: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 19: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 20: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 21: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 22: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Asia-Pacific
Figure 23: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 24: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 25: Europe OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 26: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 27: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 28: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 29: Forces Driving Competition in the OTC Pharmaceuticals Market in Europe
Figure 30: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Europe
Figure 31: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Europe
Figure 32: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Europe
Figure 33: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Europe
Figure 34: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Europe
Figure 35: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 36: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 37: Belgium OTC Pharmaceuticals Market Value: $ million, 2004- 2008(e)
Figure 38: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 39: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 40: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 41: Forces Driving Competition in the OTC Pharmaceuticals Market in Belgium
Figure 42: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Belgium
Figure 43: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Belgium
Figure 44: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Belgium
Figure 45: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Belgium
Figure 46: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Belgium
Figure 47: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 48: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
Figure 49: Canada OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 50: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 51: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 52: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 53: Forces Driving Competition in the OTC Pharmaceuticals Market in Canada
Figure 54: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Canada
Figure 55: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Canada
Figure 56: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Canada
Figure 57: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Canada
Figure 58: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Canada
Figure 59: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 60: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 61: China OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 62: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 63: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 64: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 65: Forces Driving Competition in the OTC Pharmaceuticals Market in China
Figure 66: Drivers of Buyer Power in the OTC Pharmaceuticals Market in China
Figure 67: Drivers of Supplier Power in the OTC Pharmaceuticals Market in China
Figure 68: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in China
Figure 69: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in China
Figure 70: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in China
Figure 71: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 72: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 73: France OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Figure 74: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 75: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 76: France OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 77: Forces Driving Competition in the OTC Pharmaceuticals Market in France
Figure 78: Drivers of Buyer Power in the OTC Pharmaceuticals Market in France
Figure 79: Drivers of Supplier Power in the OTC Pharmaceuticals Market in France
Figure 80: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in France
Figure 81: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in France
Figure 82: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in France
Figure 83: France OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 84: France OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 85: Germany OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 86: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 87: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 88: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 89: Forces Driving Competition in the OTC Pharmaceuticals Market in Germany
Figure 90: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Germany
Figure 91: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Germany
Figure 92: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Germany
Figure 93: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Germany
Figure 94: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Germany
Figure 95: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 96: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 97: Italy OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Figure 98: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 99: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 100: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 101: Forces Driving Competition in the OTC Pharmaceuticals Market in Italy
Figure 102: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Italy
Figure 103: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Italy
Figure 104: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Italy
Figure 105: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Italy
Figure 106: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Italy
Figure 107: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 108: Italy OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 109: Japan OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Figure 110: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 111: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 112: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 113: Forces Driving Competition in the OTC Pharmaceuticals Market in Japan
Figure 114: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Japan
Figure 115: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Japan
Figure 116: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Japan
Figure 117: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Japan
Figure 118: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Japan
Figure 119: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 120: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 121: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004-2 2008(e)
Figure 122: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 123: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 124: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 125: Forces Driving Competition in the OTC Pharmaceuticals Market in the Netherlands
Figure 126: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the Netherlands
Figure 127: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the Netherlands
Figure 128: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the Netherlands
Figure 129: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the Netherlands
Figure 130: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the Netherlands
Figure 131: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 132: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
Figure 133: Spain OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Figure 134: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 135: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 136: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 137: Forces Driving Competition in the OTC Pharmaceuticals Market in Spain
Figure 138: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Spain
Figure 139: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Spain
Figure 140: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Spain
Figure 141: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Spain
Figure 142: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Spain
Figure 143: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 144: Spain OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 145: United Kingdom OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e)
Figure 146: United Kingdom OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 147: United Kingdom OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 148: United Kingdom OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 149: Forces Driving Competition in the OTC Pharmaceuticals Market in the United Kingdom
Figure 150: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the United Kingdom
Figure 151: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the United Kingdom
Figure 152: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the United Kingdom
Figure 153: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the United Kingdom
Figure 154: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the United Kingdom
Figure 155: United Kingdom OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 156: United Kingdom OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 157: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e)
Figure 158: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 159: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 160: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 161: Forces Driving Competition in the OTC Pharmaceuticals Market in the United States
Figure 162: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the United States
<
DD>Figure 163: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the United States
Figure 164: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the United States
Figure 165: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the United States
Figure 166: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the United States
Figure 167: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)
Figure 168: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 169: Revenues & Profitability: Pfizer Inc
Figure 170: Revenues & Profitability: GlaxoSmithKline Plc
Figure 171: Revenues & Profitability: Novartis AG
Figure 172: Revenues & Profitability: Bayer AG






Abstract

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report
  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry
Highlights

The global OTC pharmaceuticals market grew by 3.9% in 2008 to reach a value of $104.2 billion.

In 2013, the market is forecast to have a value of $124 billion, an increase of 19% since 2008.

Sales of traditional medicines account for 20.3% of the global OTC pharmaceutical market's overall value.

The Asia-Pacific accounts for 38.2% of the global OTC pharmaceutical market's value.

Pfizer generates the largest share of the global OTC pharmaceutical market's value, accounting for a 6.1%

Pharmacies and drug stores distribute 57.8% of the value in the global OTC pharmaceutical market.

Why you should buy this report
  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
Market Definition

The OTC pharmaceuticals market values the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin, other analgesics), and other OTC healthcare products including; medicated skin products (anti-bacterials, acne treatments, anti-fungals, other medicated skin products, disinfectants), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, other tape or bandage, liquid bandages), first aid kits and other OTC healthcare products (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, motion sickness).

The market values are at retail selling price (RSP) and include any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2007 annual average exchange rates.

For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009